Euclidean Capital as of Dec. 31, 2020
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 54.4 | $257M | 4.2M | 61.51 | |
| Ngm Biopharmaceuticals | 13.4 | $63M | 2.1M | 30.30 | |
| Oric Pharmaceuticals (ORIC) | 10.0 | $47M | 1.4M | 33.85 | |
| Denali Therapeutics (DNLI) | 5.7 | $27M | 324k | 83.76 | |
| Foghorn Therapeutics (FHTX) | 5.4 | $26M | 1.3M | 20.27 | |
| Constellation Pharmceticls I | 3.4 | $16M | 554k | 28.80 | |
| Alector (ALEC) | 3.1 | $15M | 981k | 15.13 | |
| Rapt Therapeutics (RAPT) | 3.1 | $15M | 736k | 19.75 | |
| Revolution Medicines (RVMD) | 0.8 | $3.7M | 93k | 39.59 | |
| First Financial Ban (FFBC) | 0.6 | $3.0M | 174k | 17.53 |
